(Q33395573)

English

A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Kristen N Ganjoo

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lee D Cranmer

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

James E Butrynski

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Daniel Rushing

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Douglas Adkins

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Scott H Okuno

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gustavo Lorente

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Stew Kroll

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Virginia K Langmuir

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sant P Chawla

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

31 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

80

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

50-56

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Stud

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

Molecular Imaging of Hypoxia

1 reference

https://api.crossref.org/works/10.1159%2F000327739

21 January 2018

Identifiers

10.1159/000327739

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33395573&oldid=1577997124"